<?xml-stylesheet type="text/xsl" href="https://www.vetsurgeon.org/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Boehringer announces first stem cell medicine for equine lameness</title><link>/b/veterinary-news/posts/boehringer-announces-first-stem-cell-medicine-for-equine-lameness</link><description> Boehringer Ingelheim Animal Health has announced the launch of Arti-Cell Forte, the first stem cell-based veterinary medicine to get marketing authorisation for treating equine lameness, calling it a &amp;#39;breakthrough medicine for degenerative joint disease</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>